De Lima-Karagiannis, A; Juillerat, Pascal; Sebastian, S; Pedersen, N; Bar-Gil Shitrit, A; van der Woude, C J (2020). Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic. Journal of Crohn's & colitis, 14(S3), S807-S814. Oxford University Press 10.1093/ecco-jcc/jjaa125
|
Text
jjaa125.pdf - Published Version Available under License Publisher holds Copyright. Download (340kB) | Preview |
The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory bowel disease [IBD]. Care for pregnant IBD patients in itself is a complex issue because of the delicate balance between controlling maternal IBD as well as promoting the health of the unborn child. This often requires continued immunosuppressive maintenance medication or the introduction of new IBD medication during pregnancy. The current global COVID-19 pandemic creates an additional challenge in the management of pregnant IBD patients. In this paper we aimed to answer relevant questions that can be encountered in daily clinical practice when caring for pregnant women with IBD during the current COVID-19 pandemic.
PODCAST
This article has an associated podcast which can be accessed at https://academic.oup.com/ecco-jcc/pages/podcast.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology |
UniBE Contributor: |
Juillerat, Pascal |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1873-9946 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Thi Thao Anh Pham |
Date Deposited: |
08 Jan 2021 16:36 |
Last Modified: |
23 Nov 2023 16:21 |
Publisher DOI: |
10.1093/ecco-jcc/jjaa125 |
PubMed ID: |
33085970 |
Uncontrolled Keywords: |
Pregnancy COVID-19 SARS-CoV2 inflammatory bowel disease |
BORIS DOI: |
10.48350/151104 |
URI: |
https://boris.unibe.ch/id/eprint/151104 |